1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics, August 2016

Pharmaceutical Analysis & Statistics, August 2016

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

1-30 of about 23 000 reports

Purchase Reports From Reputable Market Research Publishers

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hospital Acquired Methicillin-Resistant Staphylococcus ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World, United Kingdom, United States
Toxoplasmosis - Pipeline Review, H1 2016

Toxoplasmosis - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Toxoplasmosis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Toxoplasmosis - Pipeline Review, H1 2016’, provides an overview of the Toxoplasmosis pipeline landscape. The report provides ...

  • Industries : Pathology, Biopharmaceutical, Therapy
  • Countries : World
Encephalopathy - Pipeline Review, H1 2016

Encephalopathy - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Encephalopathy - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Encephalopathy - Pipeline Review, H1 2016’, provides an overview of the Encephalopathy pipeline landscape. The report provides ...

  • Industries : Pathology, Mental Health, Therapy, Pharmaceutical
  • Countries : United States
Ignyta, Inc. - Product Pipeline Review - 2016

Ignyta, Inc. - Product Pipeline Review - 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Ignyta, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Ignyta, Inc. - Product Pipeline Review - 2016’, provides an overview of the Ignyta, Inc.’s pharmaceutical research ...

  • Industries : Cancer, Pathology
  • Countries : United States
Poliomyelitis - Pipeline Review, H1 2016

Poliomyelitis - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Poliomyelitis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Poliomyelitis - Pipeline Review, H1 2016’, provides an overview of the Poliomyelitis pipeline landscape. The report provides ...

  • Industries : Pathology, Therapy, Biopharmaceutical, Healthcare
  • Countries : United States, World
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2016’, provides an overview of the Live ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : United States
Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2016’, provides ...

  • Industries : Pathology, Therapy, Healthcare
  • Countries : United States
Myocardial Fibrosis - Pipeline Review, H1 2016

Myocardial Fibrosis - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Myocardial Fibrosis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Myocardial Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Myocardial Fibrosis pipeline landscape. ...

  • Industries : Therapy, Pathology, Pharmaceutical, Cancer
  • Countries : United States
Liposarcoma - Pipeline Review, H1 2016

Liposarcoma - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Liposarcoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H1 2016’, provides an overview of the Liposarcoma pipeline landscape. The report provides comprehensive ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016’, provides an overview of the Herpes ...

  • Industries : Therapy, Biopharmaceutical, Pharmaceutical, Pathology, Research and Development, Biotechnology
  • Countries : United States
Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016

Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Pituitary ACTH Hypersecretion (Cushing Disease) - Pipeline Review, H1 2016’, provides ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States
Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016

Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H1 2016’, provides an overview ...

  • Industries : Pharmaceutical, Therapy, OTC
  • Countries : United States
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Pipeline Review, H1 2016

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) ...

  • Industries : Pathology, Therapy, Pharmaceutical, Healthcare
  • Countries : United States, World, Europe
Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016

Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016’, provides an overview of the Sicca Syndrome (Sjogren) pipeline ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Sangamo BioSciences, Inc. - Product Pipeline Review - 2016’, provides an overview of the Sangamo BioSciences, ...

  • Industries : Research and Development, Biological Therapy, Pathology, Therapy
  • Countries : United States
Hyperglycemia - Pipeline Review, H1 2016

Hyperglycemia - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Hyperglycemia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hyperglycemia - Pipeline Review, H1 2016’, provides an overview of the Hyperglycemia pipeline landscape. The report provides ...

  • Industries : Therapy, Pharmaceutical, Pathology, Chronic Disease
  • Countries : United States
Medulloblastoma - Pipeline Review, H1 2016

Medulloblastoma - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Medulloblastoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Medulloblastoma - Pipeline Review, H1 2016’, provides an overview of the Medulloblastoma pipeline landscape. The report ...

  • Industries : Cancer, Pathology
  • Countries : United States
Nanotherapeutics, Inc. - Product Pipeline Review - 2016

Nanotherapeutics, Inc. - Product Pipeline Review - 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Nanotherapeutics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Nanotherapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the Nanotherapeutics, Inc.’s ...

  • Industries : Therapy, Pathology, Biopharmaceutical, Research and Development
  • Countries : United States
Hypertension - Pipeline Review, H1 2016

Hypertension - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Hypertension - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2016’, provides an overview of the Hypertension pipeline landscape. The report provides ...

  • Industries : Chronic Disease, Pathology
  • Countries : United States
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016’, provides an overview of the Retinitis Pigmentosa ...

  • Industries : Pathology, Therapy, Research and Development, Biological Therapy
  • Countries : United States
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cance ...

  • Industries : Cancer, Pathology
  • Countries : United States
Streptococcal Pneumonia - Pipeline Review, H1 2016

Streptococcal Pneumonia - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Streptococcal Pneumonia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Streptococcal Pneumonia - Pipeline Review, H1 2016’, provides an overview of the Streptococcal Pneumonia pipeline ...

  • Industries : Pathology, Biopharmaceutical, Therapy, Healthcare
  • Countries : World
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2016

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, ...

  • Industries : Therapy
  • Countries : United States
Retinopathy - Pipeline Review, H1 2016

Retinopathy - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Retinopathy - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Retinopathy - Pipeline Review, H1 2016’, provides an overview of the Retinopathy pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare, Therapy
  • Countries : United States
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, ...

  • Industries : Pathology, Therapy, Pharmaceutical, Healthcare
  • Countries : United States
Age Related Macular Degeneration - Pipeline Review, H1 2016

Age Related Macular Degeneration - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Age Related ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Short Bowel Syndrome - Pipeline Review, H1 2016

Short Bowel Syndrome - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Short Bowel Syndrome - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Short Bowel Syndrome - Pipeline Review, H1 2016’, provides an overview of the Short Bowel Syndrome pipeline landscape. ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States, World, Europe
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016’, provides an overview of the Bile ...

  • Industries : Cancer, Pathology
  • Countries : United States
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2016

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2016

  • $ 42 521
  • Company report
  • May 2016
  • by Global Markets Direct

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2016’, provides ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
About 39 000 reports

Download Unlimited Documents from Trusted Public Sources

Cholesterol Statistics in the US

  • August 2016
    79 pages
  • Cholesterol  

    Cardiovascular ...  

    Therapy  

  • United States  

View report >

Therapy Market

August 2016

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.